Sinilnikova, O. M., Antoniou, A. C., Simard, J., Healey, S., Léoné, M., Sinnett, D., . . . Davidson, R. (2009). The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Citação norma ChicagoSinilnikova, Olga M., et al. The TP53 Arg72Pro and MDM2 309G>T Polymorphisms Are Not Associated With Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers. 2009.
Citação norma MLASinilnikova, Olga M., et al. The TP53 Arg72Pro and MDM2 309G>T Polymorphisms Are Not Associated With Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers. 2009.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.